Increased Protein Glycation in Fructosamine 3-kinase-deficient Mice
Overview
Authors
Affiliations
Amines, including those present on proteins, spontaneously react with glucose to form fructosamines in a reaction known as glycation. In the present paper, we have explored, through a targeted gene inactivation approach, the role of FN3K (fructosamine 3-kinase), an intracellular enzyme that phosphorylates free and protein-bound fructose-epsilon-lysines and which is potentially involved in protein repair. Fn3k-/- mice looked healthy and had normal blood glucose and serum fructosamine levels. However, their level of haemoglobin-bound fructosamines was approx. 2.5-fold higher than that of control (Fn3k+/+) or Fn3k+/- mice. Other intracellular proteins were also significantly more glycated in Fn3k-/- mice in erythrocytes (1.8-2.2-fold) and in brain, kidney, liver and skeletal muscle (1.2-1.8-fold), indicating that FN3K removes fructosamines from intracellular proteins in vivo. The urinary excretion of free fructose-epsilon-lysine was 10-20-fold higher in fed mice compared with mice starved for 36 h, and did not differ between fed Fn3k+/+ and Fn3k-/- mice, indicating that food is the main source of urinary fructose-epsilon-lysine in these mice and that FN3K does not participate in the metabolism of food-derived fructose-epsilon-lysine. However, in starved animals, the urinary excretion of fructose-epsilon-lysine was 2.5-fold higher in Fn3k-/- mice compared with Fn3k+/+ or Fn3k+/- mice. Furthermore, a marked increase (5-13-fold) was observed in the concentration of free fructose-epsilon-lysine in tissues of fed Fn3k-/- mice compared with control mice, indicating that FN3K participates in the metabolism of endogenously produced fructose-epsilon-lysine. Taken together, these data indicate that FN3K serves as a protein repair enzyme and also in the metabolism of endogenously produced free fructose-epsilon-lysine.
Structural basis for FN3K-mediated protein deglycation.
Lokhandwala J, Matlack J, Smalley T, Miner 3rd R, Tran T, Binning J Structure. 2024; 32(10):1711-1724.e5.
PMID: 39173621 PMC: 11455621. DOI: 10.1016/j.str.2024.07.018.
A Role for Advanced Glycation End Products in Molecular Ageing.
Zgutka K, Tkacz M, Tomasiak P, Tarnowski M Int J Mol Sci. 2023; 24(12).
PMID: 37373042 PMC: 10298716. DOI: 10.3390/ijms24129881.
Anti-Glucotoxicity Effect of Phytoconstituents Inhibiting MGO-AGEs Formation and Breaking MGO-AGEs.
Yadav N, Palkhede J, Kim S Int J Mol Sci. 2023; 24(8).
PMID: 37108833 PMC: 10141761. DOI: 10.3390/ijms24087672.
Leveraging histone glycation for cancer diagnostics and therapeutics.
Knorlein A, Xiao Y, David Y Trends Cancer. 2023; 9(5):410-420.
PMID: 36804508 PMC: 10121827. DOI: 10.1016/j.trecan.2023.01.005.
Masania J, Wijten P, Keipert S, Ost M, Klaus S, Rabbani N Redox Biol. 2022; 59:102574.
PMID: 36521306 PMC: 9772855. DOI: 10.1016/j.redox.2022.102574.